Ionis Pharmaceuticals Inc financial data

Symbol
IONS on Nasdaq
Industry
Pharmaceutical Preparations
Location
2855 Gazelle Court, Carlsbad, CA
State of incorporation
California
Fiscal year end
December 31
Former names
ISIS PHARMACEUTICALS INC (to 12/18/2015)
Latest financial report
10-Q - Q2 2024 - Aug 1, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 671 % -19.4%
Quick Ratio 7.61 % -3.92%
Debt-to-equity 801 % +91.1%
Return On Equity -90.8 % -8475%
Return On Assets -12.9 % -12.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 146M shares +2.01%
Common Stock, Shares, Outstanding 146M shares +2%
Entity Public Float 4.24B USD +11.5%
Common Stock, Value, Issued 146K USD +2.1%
Weighted Average Number of Shares Outstanding, Basic 146M shares +2%
Weighted Average Number of Shares Outstanding, Diluted 146M shares +2%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 325M USD +114%
Revenue from Contract with Customer, Excluding Assessed Tax 813M USD +29%
Costs and Expenses 1.18B USD +6.93%
Operating Income (Loss) -365M USD +22.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -353M USD -25.3%
Income Tax Expense (Benefit) 13.2M USD -52%
Net Income (Loss) Attributable to Parent -366M USD -18.3%
Earnings Per Share, Basic -2.52 USD/shares -16.1%
Earnings Per Share, Diluted -2.52 USD/shares -16.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 294M USD -30.8%
Inventory, Net 28.7M USD +12.5%
Other Assets, Current 195M USD +9.47%
Assets, Current 2.33B USD -11%
Property, Plant and Equipment, Net 75.9M USD -17.2%
Operating Lease, Right-of-Use Asset 167M USD -5.53%
Other Assets, Noncurrent 119M USD +38.2%
Assets 2.69B USD -9.42%
Accounts Payable, Current 9.24M USD -61.5%
Employee-related Liabilities, Current 35M USD +19.4%
Accrued Liabilities, Current 114M USD +9.15%
Contract with Customer, Liability, Current 94.1M USD -2.27%
Liabilities, Current 306M USD +6.32%
Contract with Customer, Liability, Noncurrent 189M USD -25.8%
Operating Lease, Liability, Noncurrent 166M USD -4.9%
Other Liabilities, Noncurrent 41.8M USD +154%
Liabilities 2.43B USD -4.54%
Accumulated Other Comprehensive Income (Loss), Net of Tax -34.8M USD +31.6%
Retained Earnings (Accumulated Deficit) -2B USD -22.3%
Stockholders' Equity Attributable to Parent 264M USD -38.4%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 315M USD -46.9%
Liabilities and Equity 2.69B USD -9.42%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -150M USD -11.9%
Net Cash Provided by (Used in) Financing Activities 23.6M USD -95.2%
Net Cash Provided by (Used in) Investing Activities 76.1M USD
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 146M shares +2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -50.4M USD -255%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 294M USD -30.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 95K USD +6.74%
Deferred Tax Assets, Valuation Allowance 978M USD +20.9%
Deferred Tax Assets, Gross 1.03B USD +19.5%
Operating Lease, Liability 179M USD -3.86%
Depreciation 2.55M USD -2.19%
Payments to Acquire Property, Plant, and Equipment 4.49M USD -57.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -350M USD -14.3%
Lessee, Operating Lease, Liability, to be Paid 280M USD -6.7%
Operating Lease, Liability, Current 8.09M USD +12.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 20.6M USD +1.25%
Lessee, Operating Lease, Liability, to be Paid, Year One 20.4M USD +1.63%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 101M USD -11.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 20.8M USD +0.68%
Deferred Tax Assets, Operating Loss Carryforwards 78M USD -11.2%
Unrecognized Tax Benefits 43.3M USD -23.5%
Lessee, Operating Lease, Liability, to be Paid, Year Four 20.8M USD +0.09%
Amortization of Intangible Assets 639K USD +5.27%
Share-based Payment Arrangement, Expense 114M USD +11%
Interest Expense 17.4M USD +124%